Reference number : 276-2010-2011-Q4-00355, amendment number : , agreement type : C, recipient legal name : ImmunoVaccine Technologies Inc.|ImmunoVaccine Technologies Inc., recipient country : CA, recipient province : NS, recipient city : Halifax|Halifax, recipient postal code : B3J 3R1, program name english : Business Development Program, program name french : Programme de développement des entreprises, program purpose english : nan, program purpose french : nan, agreement title english : 198805, agreement title french : 198805, agreement number : 198805, agreement value : 77000.0, agreement start date : 2011-03-08, agreement end date : 2011-03-31, description english : Commercialization and business development activities, description french : Activités de commercialisation et de développement, expected results english : nan, expected results french : nan, additional information english : The assistance type is Unconditionally Repayable Contribution., additional information french : Le type d'aide est Contribution à remboursement inconditionnel., owner organization : acoa-apeca, owner organization title : Atlantic Canada Opportunities Agency | Agence de promotion économique du Canada atlantique